GRZAN Panama Medical Device Registration Services: Scope and Delivery

1. Key takeaways

A foreign manufacturer cannot complete medical device registration in Panama on its own. The product must be submitted by a local proveedor holding a DNDM operating licence (Licencia de Operación); foreign documents require an apostille; documents not in Spanish must be translated by a Panamanian public authorised translator; and the vigilance system must designate at least one qualified professional who interfaces with DNDM. GRZAN delivers through a combination of a registration team and a local licensed partner. The registration team handles classification, dossier preparation, translation coordination and submission strategy; the local partner supplies the licensed entity, the submission window and the vigilance counterpart. The regulations covered by the fifty articles in this volume form the legal base for that work. Wherever an official figure, period or amount has not been published, we mark it as a practical estimate or as subject to the current DNDM position rather than committing to it.

2. Legal basis

The table maps each service module to the provision that drives it. It is not a price list or a timetable; it is the link between a deliverable and the article that makes it necessary, so that a client can see which requirement a work package is answering and which article would be cited if the authority raised a question.

3. Expert insights

Insight 1: the bottleneck in Panama is usually the dossier rather than the review. DE 490 writes the formal requirements in detail: seventeen instruction items in Article 38, twelve label items in Article 40, apostille under Article 35, twelve import invoice items under Article 27, and an express prohibition on relabelling and overlabelling in Article 39 item 4. Most correction notices are not technical rejections but formal mismatches. Our practice is to run an article-by-article check before submission rather than to amend after a notice arrives.

Insight 2: ISO 13485 has moved from optional to a hard threshold. The original Article 37 of DE 490 treated ISO 13485 as optional for class D devices. After DE 416 of 13 May 2020 rewrote Article 36 item 10, a currently valid ISO 13485 certificate became one of the general requirements for imported devices. A number of sources still repeat the older position, which is a frequent reason for a returned file.

Insight 3: the choice of local representative determines long-term compliance cost. Under Article 43, with two company-side substantial changes, and Article 67 items 2 and 9, where a change of manufacturer or a revocation of authorisation are both cancellation grounds, the cost of replacing a representative approaches that of a fresh market entry. We advise placing the representative role, at the point of first entry, in an entity that can sustainably carry vigilance and recall duties.

Insight 4: we keep uncertain items explicitly blank. Article 18 of Ley 92 leaves the start date of sanitary registration with the health authority and it has not been published; the proposed adoption date of PAN/135 is pending; and Article 26 of DE 490 allows fees to be updated by administrative decree. For these items we give no assumed figure and mark them as subject to the current DNDM position, which is both the compliance answer and the only way to prevent a client scheduling production against a wrong timetable.

4. Practical recommendations

• Classify before discussing documents. Fix the A, B, C or D class under Article 30 of DE 490, applying the higher class where two are met, then determine the document set from the add-on rules in Article 37, so that time and cost are not spent preparing everything to the highest class.
• Get the document chain right the first time. Apostille foreign documents under Article 35, with directory-type documents exempt; have Spanish translation done by a Panamanian public authorised translator; issue the representation letter with the six items of Comunicado 009.
• Write the post-certificate obligations into the project plan. The five-year CCT under Article 21, the five-year licence with renewal 60 working days before expiry under Article 13, the 72-hour vigilance report under Article 56 and implant traceability under Article 62 all start counting on the day the certificate is issued.
• Do not wait during the transition. The adoption of PAN/135 is pending and DE 490 remains in force, so we advise filing under the current rules while preparing the three capabilities for IVD, traceability and advertising copy.
• State the limits of what we can commit to. GRZAN does not promise a number of working days for DNDM review, a date for the opening of sanitary registration or a fee amount; all three follow what DNDM publishes at the time.

5. Verification checklist

• □ Confirmed whether the product falls under Article 5 of Ley 90 or requires joint classification by DNDM and DNFD under Article 11
• □ Risk class anticipated under Article 30 of DE 490, with the higher-class rule accepted
• □ Valid ISO 13485 available for submission, or a certification route planned
• □ Country of origin and country of provenance identified under definitions 34 and 35 of Ley 90, with the CFS issuing body confirmed
• □ Apostille obtainable for foreign documents, with directory-type documents exempt
• □ Spanish translation available from a Panamanian public authorised translator
• □ Local proveedor identified and able to issue the representation letter under Comunicado 009
• □ Four post-certificate clocks scheduled: five-year CCT, five-year licence with 60 working days, 72-hour vigilance, implant traceability
• □ Uncertain items, namely the registration start date, review working days and fees, handled as subject to the current DNDM position

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Panamanian market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com